Skip to main content
European Radiology Experimental

Table 6 Univariate and multivariate regression analysis for risk factors of major complication

From: The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease

 

Univariate analysis

Multivariate analysis

OR

95% CI

p-value

OR

95% CI

p-value

Age > 65 years

6.444

1.274–32.593

0.020

4.274

0.242–75.356

0.321

Gender (male)

0.420

0.122–1.449

0.170

   

Diagnosis

 Ulcerative colitis

1

     

 Crohn

3.167

0.648–15.474

0.154

   

 Indeterminate colitis

3.167

0.215–46.726

0.401

   

BMI category

 Underweight

1

 

0.631

   

 Normal

0.435

0.063–3.021

0.400

   

 Overweight

0.375

0.035–3.999

0.417

   

 Obese

0.214

0.021–2.187

0.194

   

ASA physical score ≥ 3

2.318

0.660–8.138

0.189

   

Charlson Comorbidity index ≥ 3

4.167

1.078–16.103

0.039

1.663

0.141–19.573

0.686

Smoking status

 Non-smoker

1

 

0.228

   

 Ex-smoker

0.684

0.131–3.578

0.653

   

 Smoker

2.778

0.734–10.513

0.132

   

NLR category > 5

4.320

1.249–14.498

0.021

4.489

1.222–16.494

0.024

Albumin > 35 g/L

0.525

0.169–1.629

0.265

   

Preoperative steroid use

1.510

0.488–4.676

0.474

   

Preoperative immunosuppression

0.502

0.156–1.617

0.248

   

Emergency surgery

2.382

0.690–8.226

0.170

   

Sarcopenia

0.925

0.297–2.878

0.893

   

Myosteatosis

1.719

0.557–5.304

0.346

   
  1. ASA American Society of Anesthesiologists, BMI Body Mass Index, CI confidence interval, NLR neutrophil-lymphocyte ratio, OR odds ratio
Back to article page